Sari IK, Pamungkas J, Mustopa AZ, et al. Preclinical Evaluation of HPV Type 52 L1L2 Chimeric Protein as a Cervical Cancer Vaccine Candidate. HAYATI J Biosci. 2025;33(3):556-565. doi:10.4308/hjb.33.3.556-565